|
 |
| ORIGINAL ARTICLE |
|
| Year : 2021 | Volume
: 12
| Issue : 2 | Page : 152-156 |
|
|
Enhanced cytotoxic effects of Clinacanthus nutans and doxorubicin in combination toward breast cancer cell lines
Sry Suryani Widjaja1, Rusdiana1, M Ichwan2
1 Department of Biochemistry, Medical Faculty Universitas Sumatera Utara, Indonesia
2 Department of Pharmacology, Medical Faculty Universitas Sumatera Utara, Indonesia
| Date of Submission | 22-Nov-2020 |
| Date of Decision | 19-Jan-2021 |
| Date of Acceptance | 24-Feb-2021 |
| Date of Web Publication | 27-Apr-2021 |
Correspondence Address:
Dr. Sry Suryani Widjaja
Department of Biochemistry, Medical Faculty, Universitas Sumatera Utara, Medan
Indonesia
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/japtr.JAPTR_251_20
Breast cancer is one of the most common cancers with a relatively high mortality rate. Despite the advancement of its medical treatments, many patients are still seeking complementary alternative medicines, namely Clinacanthus nutans which is found mainly in South-East Asian countries. We aim to find the antioxidant properties and cytotoxic activity of the plant extract toward breast cancer cell lines Michigan Cancer Foundation-7 (MCF7) and T47D individually and in combination with doxorubicin. Extractions of C. nutans with ethanol, n-hexane, and ethyl acetate were done using rotatory vacuum evaporators with the reflux method. Screening of biochemical properties was conducted. Antioxidant activity was measured toward α, α-diphenyl-β-picrylhydrazyl (DPPH) with IC50 scores were shown to be highest in ethyl acetate extract. Cytotoxic effects of all three extracts were shown to be low in both MCF7 and T47D cells. However, combinations of 125 μg/ml n-hexane extract of C. nutans, and 0.1 μg/ml doxorubicin in T47D cancer cells showed further proliferation reduction compared to the single administration. The results suggested possible synergisms of the treatment combination.
Keywords: Antioxidant, breast cancer, Clinacanthus nutans, cytotoxic, doxorubicin
How to cite this article:
Widjaja SS, Rusdiana, Ichwan M. Enhanced cytotoxic effects of Clinacanthus nutans and doxorubicin in combination toward breast cancer cell lines. J Adv Pharm Technol Res 2021;12:152-6 |
How to cite this URL:
Widjaja SS, Rusdiana, Ichwan M. Enhanced cytotoxic effects of Clinacanthus nutans and doxorubicin in combination toward breast cancer cell lines. J Adv Pharm Technol Res [serial online] 2021 [cited 2023 Mar 29];12:152-6. Available from: https://www.japtr.org/text.asp?2021/12/2/152/314674 |
| Introduction | |  |
Breast cancer has consistently been the most common type of cancer ranks 3rd to 4th as the cause of mortality.[1] GLOBOCAN 2018 showed that the number of new breast cancer cases is 2,088,849 with the number of deaths 626,679.[2] Despite its high incidence, the survival rates of breast cancer have increased to nearly >90% and 89% in 5-year, respectively.[1] Global initiatives have established therapeutic intervention guidelines for surgery, chemotherapy, and radiation therapy for breast cancer patients. However, there are more or less of 55% of cancer patients who are still searching for alternative treatments to be used in combination to or even substituting their primary medical therapies.[3] A study by Akhtar et al.[4] showed that 98% of patients believe that there is no harm in taking herbal medicine therapies and often think of combining it with their primary medical treatment.
Some of the herbs commonly used to treat breast cancer are Echinacea, Allium sativum or garlic, Curcuma longa or turmeric, Camellia sinensis or green tea, Panax ginseng or ginseng, flaxseed, and Arctium lappa or burdock. They contain substances with antioxidant, antimutagenic, and antiproliferative activity, which were proven to inhibit cancer cell growth.[5]
One of the rising potential alternative treatments is Clinacanthus nutans from the family Acanthaceae or commonly termed elephant trunk leaf (“daun belalai gajah” [Indonesia]), Sabah snake grass (Malaysia), “you dun cao” (China), and “slaed pang pon” (Thai).[6],[7] The plant itself has gained its popularity as an alternative therapy for viral skin lesions such as herpes simplex virus infection types 1 and 2, snake venom, and other insect bites antidote, antifever, and even as a diuretic agent. It possesses anti-inflammatory actions as well as significant inhibitory effects toward superoxide anion and elastase.[6] Ethanol extract of C. nutans was shown to have an immunomodulating effect with apoptotic expressions toward human neutrophil cells and porcine peripheral blood mononuclear cells. In addition, inhibition of cell proliferation and cytotoxic effects have been found in vitro, particularly in HeLa and K-562 cells with a tested dose of 18.0 and 20.0 μg/mL, respectively. Moreover, antioxidant activity has also been shown using a free radical assay.[7]
It is still, however, limited evidence of the potential anticancerous effect of C. nutans toward breast cancer cells.[6],[7] Some of the most frequently used breast cancer cell lines are the Michigan Cancer Foundation-7 (MCF7) and T47D, mainly due to their hormone-dependent characteristics and their expression of estrogen receptors.[8] In this study, we aim to find the potency of antioxidant and cytotoxic activity of C. nutans leaf extract toward breast cancer cell (MCF7 and T47D) growth, individually and/or in combination with doxorubicin.
| Materials and Methods | | |
Extraction of Clinacanthus nutans using ethanol, N-hexane, and ethyl acetate
Extraction of C. nutans with ethanol, N-hexane, and ethyl acetate was carried out through a reflux method by mixing 50 g of finely dry-powdered leaves with 500 mL 100% ethanol/N-hexane/ethyl acetate.
Biochemical properties of Clinacanthus nutans
The chemical components contained in the plant ethanolic extract were analyzed using the high-performance liquid chromatography with tandem mass-spectrometry and two mass analyzers (MS/MS). The results were shown using the software Compound Discoverer with mzCloud MS/MS Library.
Antioxidant property measurement
Our method in measuring the antioxidant property of C. nutans was adapted from Molyneux,[9] which is to find the IC50 score or the inhibitory concentration (concentration of samples sufficient to attenuate 50% of a free radical agent's oxidative process) toward α, α-diphenyl-β-picrylhydrazyl (DPPH; C18H12N5O6, M = 394.33)).
Analysis of IC50
The rate of color intensity reduction of DPPH is calculated by the formula below.
Abs control = absorbance reading of DPPH before the addition of samples
Abs sample = absorbance reading of a mixture of DPPH and sample extract
The value of 0% is defined as no antioxidant activity, while 100% score means a total reduction of the violet color. The results are plotted to a linear regression equation, such as the concentrations of the C. nutans extract (μg/mL) as the X-axis and the rate of color intensity reduction or the antioxidant activity as the Y ordinate using the software Statistical Package for Social Sciences (SPSS) V 21.0.[10] The classifications of the compounds according to the strength of the antioxidant property were as follows: very strong (IC50 < 50 parts per million (ppm = μg/mL), strong (IC50 50–100 ppm), moderate (IC50 100–150 ppm), and weak (IC50 > 150 ppm).[11]
Total phenol content measurement with Folin-Ciocalteu method
Measurement of sample's phenol component was prepared by diluting 50 mg of the extract with methanol (1000 ppm). 0.1 mL of the diluted extract was also added to 7.9 mL aquadest and 0.5 mL of Folin-Ciocalteu reagent, the absorbance of the solution is measured at wavelength 775 nm using spectrophotometry for three times.
Total flavonoid content measurement with a colorimetric method
About 50 mg of quercetin (used as standard) and 50 mg of the extract were each diluted with 50 mL of methanol (100 ppm). About 2 mL of each concentration of the quercetin (100 ppm, 50 ppm, 25 ppm, 12.5 ppm, and 6.25 ppm) and 2 mL of the diluted extract were individually pipetted to 0.1 mL The absorbances were measured for three times at 432 nm using the spectrophotometer.
Cell lines and culture
Breast cancer cell lines MCF-7 and T47D were purchased from ATCC; the cells were grown and maintained in DMEM-F12 complete media supplemented with 10% fetal bovine serum, gentamycin in a 5% CO2 incubator with the environmental temperature of 37°C.
Cytostatic effect measurement
We used MTT assay to test the in vitro cytotoxic effect of the ethanol 96% extract, ethyl acetate, and n-hexane extract of C. nutans toward cancer cell MCF7 and T47D with and/or without doxorubicin.[12] Cancer cells were retrieved from the CO2 incubator and were examined for their conditions. When the cells reached 80% of confluence, they would be harvested. The cells were incubated for a night to enhance recovery after the harvesting process.[13] About 100 μL of MTT reagent was added to each well, including the controls. We use an ELISA reader with 550–600 nm and the results were converted to cell-survival rate (%) where relative viability = (experimental absorbance − background absorbance)/(absorbance of untreated controls − background absorbance) × 100.[14]
| Results and Discussion | | |
The lists of the primary chemical metabolites found in the extract are shown in [Table 1]. | Table 1: Analysis of the biochemical compounds found in the ethanol extract of Clinacanthus nutans with liquid chromatography with tandem mass spectrometry method
Click here to view |
We find some primary metabolites contained in C. nutans, which were not mentioned in previous studies such as a hydroxycoumarin derivative called 4-methylumbelliferone, cinnamic acids like 4-methoxycinnamic acid and sinapinic acid, and a flavonoid, namely (+)-dihydromyricetin. Scientific investigations conducted before this study have shown extensive primary metabolites in C. nutans stem and leaves extracts, including the vital phytochemicals of this plant, namely stigmasterol, lupeol, b-sitosterol, belutin, and myricyl alcohol as well as the six C-glycosyl flavones, five glucosides, and finally, eight compounds related to chlorophyll a and chlorophyll b.[6],[7]
To ensure that the extraction of the leaf does not cause any structural damage to the essential metabolites, a qualitative assessment of the phytochemical properties in the ethanol extract form and in dry powder form of the C. nutans was carried out using specific tests to visually confirm the existence of each secondary metabolite as shown in [Table 2]. | Table 2: Comparison of the phytochemical contents in the simplicial powder and ethanol extract of Clinacanthus nutans
Click here to view |
Different solvents used for extraction will give a different value of phenolic and flavonoid as shown in [Table 3] and [Table 4], also reported by Wakeel et al.[15] | Table 3: Total flavonoid content of the ethanol extract, N-hexane fraction, and ethyl acetate fraction of Clinacanthus nutans
Click here to view |
 | Table 4: Total phenolic content of the ethanol extract, N-hexane fraction, and ethyl acetate fraction of Clinacanthus nutans
Click here to view |
The amount of phenolic and flavonoid content, as well as the antioxidant activity of C. nutans extracts (1 mg/mL), varied with the range of 17.12–44.13 mg/g GAE (TPC), 14.08–30.80 mg/g QE (TFC), and DPPH inhibition of 38.1%–58%.
We also compare the activity of C. nutans with quercetin, a type of flavonols, in measuring IC50 toward DPPH; it was reported in [Table 5]. | Table 5: Comparison of half maximal inhibitory concentration between all Clinacanthus nutans extracts and quercetin toward a, α-diphenyl-β-picrylhydrazyl
Click here to view |
We found that ethyl acetate fraction, which had the highest antioxidant activity compared to the other two extraction methods, still had an efficacy of ten times less than quercetin against DPPH. However, the ethyl acetate fraction did not have the highest TPC and TFC in this study compared to ethanolic and N-hexane extracts. In a previous study by Yuann et al.,[16] antioxidant activity against DPPH, superoxide dismutase activity, and the TPC of green tea was found to be higher than C. nutans with the latter were almost reaching 10-fold.
Phenolic compounds have a hydroxyl-bearing aromatic ring skeleton that could exert anti-inflammatory, antioxidant, cytotoxicity, antimicrobial, and antiallergic actions.[17] Flavonoids and their glycosides are the main components of phenolic compound and it consists of a C6-C3-C6 skeleton, which is derived from 1,3-diphenylpropane.[17] Many plants such as the ones from the Moraceae family have isoprenylated flavonoids which were proven to show cytotoxic activity in MCF7.[18] There are six known C-glycosyl flavones, which were isolated in previous studies from butanol and methanol solvents of C. nutans, namely shaftoside, isomollupentin 7-O--glucopyranoside, orientin, isoorientin, vitexin, and isovitexin.[19] These flavones are considered rare with suspected antimicrobial, hepatoprotective, and antioxidant activity.[19]
The IC50 of cytotoxic activity toward breast cancer cell lines T47D were measured between all extracts and chemotherapeutic agent doxorubicin individually and in combination to one another. The cytotoxic effect of the C. nutans extracts showed weak cytotoxic activity toward both breast cancer cell lines [Table 6]; the concentrations of all three extracts were found to be lower in T47D compared to MCF7 cells. In addition, N-hexane extract of C. nutans showed the lowest concentration required to obtain 50% inhibition of both cancer cell lines' growth. N-hexane extract of C. nutans showed the lowest IC50, in another previous experiment by Pannangpetch et al.,[20] ethanolic extract of C. nutans showed antitumor activity with IC50 of 110.40 ± 6.59 μg/mL, which was 59 times less potent compared to ascorbic acid with IC50 of 9.72 ± 0.56 μg/mL. These findings suggest that tumor-specific activity might be exhibited by the ethanolic extract of the plant. However, it is not considered as an active anticancer agent according to the National Cancer Institute due to the IC50 value being >20 μg/mL. | Table 6: Half maximal inhibitory concentration data of the cytotoxic effect on Michigan Cancer Foundation-7 and T47D cancer cells without doxorubicin
Click here to view |
The reduction of T47D cell viability after administering N-hexane extract and doxorubicin separately is shown in [Table 7]. | Table 7: Reduction of T47D cell viability postadministering N-hexane extract of Clinacanthus nutans and doxorubicin separately
Click here to view |
When administered separately, we obtained 44.64% and 47.67% viability of the T47D breast cancer cells, but when administered combined with 0.1 μg/ml doxorubicin, the average reduction of cancer cell viability is 22.87%.
There are still minimal findings on synergistic effects yielded by a combination of C. nutans and doxorubicin. However, a study conducted by Hii et al.[21] found synergies of nonpolar stem extracts of C. nutans and gemcitabine toward the inhibition of pancreatic ductal adenocarcinoma cell lines AsPC1, BxPC3, and SW1990 up to reducing the later dose by 2.38–5.28 folds. Doxorubicin was also found to have additive cytotoxic effects when combined with aqueous Mucuna pruriens leaf extracts.[22]
| Conclusion | | |
C. nutans showed a minimum level of antioxidants as well as antitumor activity compared to other herbal alternatives. However, we found that the combination of C. nutans and doxorubicin yields more reduction of cancer cell viability hence suggesting synergistic cytotoxic effect.
Acknowledgment
This study was supported by the Ministry of Research and Technology and Higher Education Republic Indonesia, under research grant DRPM.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
| References | | |
| 1. | Momenimovahed Z, Salehiniya H. Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer (Dove Med Press) 2019;11:151-64.  |
| 2. | Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;0:1-31. |
| 3. | Buckner CA, Lafrenie RM, Dénommée JA, Caswell JM, Want DA. Complementary and alternative medicine use in patients before and after a cancer diagnosis. Curr Oncol 2018;25:e275-81. |
| 4. | Akhtar K, Akhtar K, Rahman MM. Use of alternative medicine is delaying health-seeking behavior by Bangladeshi breast cancer patients. Eur J Breast Health 2018;14:166-72. |
| 5. | Shareef M, Ashraf MA, Sarfraz M. Natural cures for breast cancer treatment. Saudi Pharm J 2016;24:233-40. |
| 6. | Khoo LW, Audrey Kow S, Lee MT, Tan CP, Shaari K, Tham CL, et al. A Comprehensive review on phytochemistry and pharmacological activities of Clinacanthus nutans (Burm.f.) Lindau. Evid Based Complement Alternat Med 2018;9276260:39. |
| 7. | Alam A, Ferdosh S, Ghafoor K, Hakim A, Juraimi AS, Khatib A, et al. Clinacanthus nutans: A review of the medicinal uses, pharmacology and phytochemistry. Asian Pacific J Trop Med 2016;9:402-9. |
| 8. | Dai X, Cheng H, Bai Z, Li J. Breast cancer cell line classification and its relevance with breast tumor subtyping. J Cancer 2017;8:3131-41. |
| 9. | Molyneux P. The use of the stable free radical diphenylpicrylhydrazyl (DPPH) for estimating antioxidant activity. Songklanakarin J Sci Technol 2004;26:211-9. |
| 10. | Shirwaikar A, Shirwaikar A, Rajendran K, Punitha IS. In vitro antioxidant studies on the benzyl tetra isoquinoline alkaloid berberine. Biol Pharm Bull 2006;29:1906-10. |
| 11. | Fidrianny I, Zahidah ES, Hartati R. Senyawa antioksidan dari ekstrak n heksana daun asam jawa ( Tamarindus indica l.) dari Banyuresmi, Garut – Indonesia. Acta Pharm Indo 2014;43:45-50. |
| 12. | Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63. |
| 13. | Cree IA. Cancer Cell Culture Methods and Protocols. 2 nd ed. New Jersey: Humana Press; 2011. |
| 14. | van Meerloo J, Kaspers GJ, Cloos J. Cell sensitivity assays: The MTT assay. Methods Mol Biol 2011;731:237-45. |
| 15. | Wakeel A, Jan SA, Ullah I, Shinwari ZK, Xu M. Solvent polarity mediates phytochemical yield and antioxidant capacity of Isatis tinctora. Peer J 2019;7:e7857. |
| 16. | Yuann JM, Wang JS, Jian HL, Lin C, Liang J. Effects of Clinacanthus nutans (Burm. f) lindau leaf extracts on protection of plasmid DNA from riboflavin photoreaction. MC-TB 2012;4:45-58. |
| 17. | Perveen S, Al Taweel AM. Phenolic compounds from the natural sources and their cytotoxicity. In: Soto Hernandez M, Palma Tenango M, Garcia Mateos MR, editors. IntechOpen.; 2017. |
| 18. | Veeramuthu D, RajaWR, Al Dhabi NA, Savarimuthu I. Flavonoids: Anti cancer properties. In: Justino G, editor. Flavonoids – From Biosynthesis to Human Health: Intech Open; 2017. |
| 19. | Teshima T, Kaneko T, Ohtani K, Kasai R, Lhieochaiphant S, licheansoonthon C, et al. C-glycosyl flavones from Clinacanthus nutans. Nat Med 1997;51:557. |
| 20. | Pannangpetch P, Laupattarakasem P, Kukongviriyapan V, Kukongviriyapan U, Kongyingyoes B, Aromdee C. Antioxidant activity and protective effect against oxidative hemolysis of Clinacanthus nutans (Burm.f) Lindau. Songklanakarin J Sci Technol 2007;29 Suppl 1:1-9. |
| 21. | Hii LW, Lim SE, Leong CO, Chin SY, Tan NP, Lai KS, et al. The synergism of Clinacanthus nutans Lindau extracts with gemcitabine: Downregulation of anti-apoptotic markers in squamous pancreatic ductal adenocarcinoma. BMC Complement Altern Med 2019;19:257. |
| 22. | Tumbas-Saponjac V, Akpoveso OO, Oyeniran OI, Desančić J, Četojević-Simin D. Antioxidant activity and enhanced cytotoxicity of aqueous Mucuna pruriens L. leaf extract by doxorubicin on different human cancer cell lines. Phcog Mag 2020;16 Suppl S1:224-8. |
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5], [Table 6], [Table 7]
|
Search Pubmed for